NewsFox 13 News (WTVT) — All NewsAugust 13, 2026Hillsborough
Ice cream manufacturers reformulate products as GLP-1 drug use rises
Ice cream companies are reducing portion sizes, increasing protein content, and removing artificial ingredients to appeal to health-conscious consumers and those using GLP-1 appetite-suppressing medications. While overall sales volumes have seen a slight decline, manufacturers are shifting strategies to maintain consumer interest in indulgent treats.
Read the full story at Fox 13 News (WTVT) — All NewsWhy It Matters
Consumers are changing their purchasing habits due to the rise of and health trends, forcing major food companies to alter product recipes and sizes to remain competitive.
Key Facts
- U.S. ice cream sales volumes declined 1.5% year-on-year through June 13.
- Approximately 16 million Americans are currently taking GLP-1 medicines.
- People taking GLP-1 drugs reduce their consumption of frozen treats by at least 10%.
- Blue Bunny reports strong demand for its 150-calorie Mini Swirls.
- Halo Top has posted double-digit percentage sales growth over the past two years.
- U.S. ice cream market dollar sales increased about 2.8% over the past year.
- Manufacturers are removing high-fructose corn syrup and artificial colors/flavors from products.
- Super-premium ice cream was the only segment to record growth in sales volume according to NielsenIQ.
Who's Mentioned
organizationCircana“Market research firm.”organizationConagra“Food company reformulating products.”organizationThe Magnum Ice Cream Company“Ice cream manufacturer.”organizationGlacier“European private-label ice cream producer.”organizationBlue Bunny“Ice cream manufacturer owned by Ferrero.”organizationNielsenIQ“Market research firm providing sales data.”organizationHalo Top“Ice cream brand owned by Ferrero.”organizationNestle“Food company reformulating products.”organizationBoston Consulting Group“Research firm providing data on GLP-1 drug usage.”